Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nina Zdinjak

Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ

Psychedelics-focused mental health company Novamind Inc. (CSE:NM) (OTCQB:NVMDF) (FSE: HN2) reported its financial results for the three and six months ended December 31, 2021.

“We’re pleased to report record high revenue this quarter driven by continued revenue growth from existing and new clinics," Novamind CEO, Yaron Conforti, stated. "Novamind is focused on providing clinical research services to leading drug developers, meeting patient demand by delivering innovative, evidence-based mental healthcare and bringing to market new treatment programs such as Psychedelic Palliative Care by Novamind and Frontline KAP.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.